The small GTPase Ral cycles between an active GTPbound and an inactive GDP-bound form. To measure activation of endogenous Ral, that is, an increase in Ral-GTP, we generated GST-Ral BD, a glutathione-S-transferase (GST) fusion protein containing the Ral-binding domain (Ral BD) of the Ral-binding protein (Ral BP), a putative Ral effector [11] . GST-Ral BD, coupled to glutathione-agarose beads, precipitates the GTP-bound form, but not the GDP-bound form of Ral [11] . Indeed, the amount of endogenous Ral recovered using GST-Ral BD from NIH3T3 cells stably expressing a constitutively active mutant of Rlf, Rlf-CAAX [2] was clearly elevated compared to the amount of Ral recovered from untransfected cells, cells expressing wild-type Rlf, or cells expressing Rlf-∆CAT-CAAX, an inactive mutant of Rlf-CAAX (Figure 1a ). This result is in agreement with previous observations that Rlf-CAAX activates epitopetagged Ral when the two are transiently co-expressed in COS-7 cells [2] . Using this method, we investigated whether activation of transmembrane receptors could also lead to activation of endogenous Ral.
We therefore stimulated Rat1 fibroblasts with plateletderived growth factor (PDGF) to activate the PDGF receptor, a receptor tyrosine kinase, and A14 cells with endothelin to activate the endothelin receptor, a serpentine receptor. In both cases, a clear increase in Ral-GTP was observed (Figure 1b) . A comparison of dilutions of the samples derived from stimulated cells with those derived from unstimulated cells revealed that the increase in Ral-GTP was about 3-5-fold. The absolute amount of Ral-GTP recovered using this method was only about a half (in the case of unstimulated cells) to 2% (in the case of stimulated cells) of the total amount of Ral present in the lysate used for the activation assay ( Figure 1c ). This might imply that only a small amount of Ral is in the active GTP-bound form. The recovery of Ral-GTP by this method is low, however, as only 3-5% of epitopetagged Ral was recovered by GST-Ral BD from lysates of A14 cells that had been transiently transfected with a construct that encodes hemagglutinin (HA)-tagged RalV23, a Ral mutant that exists largely in the GTP-bound state (Figure 1d ) [11] . Therefore, we estimate that the basal level of Ral-GTP is in the order of 10%, in agreement with the basal level of GTP bound to epitope-tagged Ral that has been expressed in cells by transfection [2, 5, 10] . No epitope-tagged Ral was recovered from A14 cells transiently expressing HA-Ral-WT or HA-RalN28, both existing largely in the GDP-bound state (Figure 1d ).
To test whether Ral activation is a common event following stimulation of receptor tyrosine kinases and serpentine receptors, several other stimuli were analysed for their ability to induce Ral activation. Ral activation was found after stimulating Rat1 cells with EGF or lysophosphatidic acid (LPA) and after stimulation of A14 cells with insulin or EGF. In addition, Ral activation was found in CCL39 cells after stimulation with PDGF or α-thrombin tested that activated Ral also activated Ras, whereas TPA and cAMP, which did not induce Ral activation, did not activate Ras in these cells either ( [12] ; data not shown).
To investigate whether Ras was indeed mediating growthfactor-induced activation of Ral, we introduced the dominant-negative Ras mutant, RasN17, into A14 cells, using a vaccinia virus vector [13] , and stimulated the cells with either insulin (Figure 3a 
Figure 2
Growth-factor-induced Ral activation. (a) Serum-starved Rat1 cells, A14 cells or CCL39 cells were stimulated with 20 ng/ml EGF, 2 µM LPA, 1 µM insulin, 25 ng/ml PDGF, 2 U/ml α-thrombin (α-Thr), 100 ng/ml TPA or 10 µM forskolin for the indicated periods of time. Ral-GTP was recovered using GST-Ral BD and analysed as described in the legend to Figure 1. (b) Time course of growth-factor-induced Ral and Ras activation. Serum-starved A14 cells or CCL39 cells were, respectively, stimulated with 1 µM insulin, or 2 U/ml α-thrombin, for the indicated periods of time. Ral-GTP and Ras-GTP were recovered, respectively, using GST-Ral BD or GST-Raf1 Ras-binding domain (RBD) [19] and analysed using, respectively, anti-Ral or anti-Ras antibodies. Myc-Ral activation was completely inhibited by RasN17 (Figure 3c ; compare levels of transfected Myc-Ral with those of the endogenous Ral, which is not inhibited by RasN17, as only a fraction of the cells are transfected with RasN17). From these results, we conclude that Ras is essential for insulin-induced activation of Ral. Together with the previous observation that Ral GEFs interact with active GTP-bound Ras, the results presented here demonstrate that the pathway from Ral GEF to Ral is a genuine effector pathway of Ras, activated by receptor tyrosine kinases and serpentine receptors. In addition to Ras-GTP, Ral GEFs were previously found to associate with the GTP-bound form of various other GTPases, including Rap1, R-Ras and TC21 [6] [7] [8] [9] . Whether the other Ras-like GTPases can mediate stimulus-induced activation of Ral is still unclear, but we recently found that, in human platelets, Ral activation correlated with the activation of Rap1 rather than Ras [11] .
The function of the pathway mediated by Ral GEF and Ral is still largely elusive. Inhibition of this pathway leads to the inhibition of DNA synthesis induced by growth factors and Ras, and Ras-induced oncogenic transformation [2] [3] [4] [5] . Furthermore, a constitutively active Ral GEF, Rlf-CAAX, induces c-fos promoter activity and cell proliferation [2] . Ral, through its amino-terminal region, interacts with phospholipase D1 [14, 15] , and Ral-GTP binds to the putative Ral effector Ral BP, also known as Ralinteracting protein (RLIP, RIP), which exhibits GTPaseactivating protein activity towards the small GTPases Cdc42 and Rac in vitro [15] [16] [17] [18] . It will therefore be of importance to examine whether Ral mediates Ras-dependent PLD and Cdc42/Rac signaling pathways.
Materials and methods

Cell culture and transfections
NIH3T3 cells, A14 cells (NIH3T3 cells expressing human insulin receptors [13] ), CCL39 cells and Rat1 cells were cultured in 100 mm dishes in DMEM supplemented with 10% fetal calf serum and 0.05% glutamine. For growth-factor studies, Rat1 cells, A14 cells and CCL39 cells were washed once with serum-free medium and serum-starved for at least 16 h. Stimulation with growth factors was as indicated in the legends of the figures. Cells were transfected by the calcium-phosphate method.
Determination of endogenous Ral and Ras activation
Ral and Ras activation were determined using GST-Ral BD and GST-Raf1 RBD, respectively, essentially as described previously [11, 19] . In brief, bacterially produced GST-Ral BD or GST-Raf1 RBD (15 µg per sample) was precoupled to glutathione-agarose beads (10 µl/sample) and washed in Ral buffer (15% glycerol, 50 mM Tris pH 7.4, 1% NP-40, 200 mM NaCl, 5 mM MgCl 2 , 1 mM PMSF, 1 µM leupeptin, 0.1 µM aprotinin, 10 µg/ml soybean trypsin inhibitor). Cells were lysed in Ral buffer and cleared lysates were split and used for the determination of Ral or Ras activity, or for the analysis of protein expression. Samples were separated on 12.5% polyacrylamide gels, immunoblotted and probed with anti-Ral (Transduction Laboratories), anti-Ras (Y13-259) or anti-HA (12CA5) monoclonal antibodies.
Infection with wild-type and recombinant vaccinia virus
His 6 -RasN17 expression vector (pEAgpt [13] ) was introduced into a viral growth factor-minus strain of vaccinia virus, and the virus was grown in HeLa cells as described [20] . A14 cells were infected with approximately 20 plaque-forming units of wild-type or recombinant virus in serum-free medium. After 60 min, the medium was replaced. To show the expression of the His 6 -tagged RasN17 protein, fractions of the total lysates were analysed by western blotting using anti-Ras antibody (upper panels).
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Ras-GTP was recovered using GST-Raf1 RBD (middle panels) and Ral-GTP was recovered using GST-Ral BD (lower panels). (c) A14 cells were transfected with 1 µg pcDNA3 Myc-Ral [2] together with
